Taking New Tack, PrimeraDx Offers MDx Tech as Open Platform for Test Developers
July 14, 2011
Taking New Tack, PrimeraDx Offers MDx Tech as Open Platform for Test Developers
Thus far, the company has inked collaborative agreements with laboratories at the MD Anderson Cancer Center and Dartmouth Medical College to develop various multi-marker oncology assays; and is pursuing partnerships with pharmaceutical companies to explore using the platform in companion diagnostic development.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- PrimeraDx Gets CE Mark for Multiplex MDx System, C. diff Assay
September 13, 2012 / PCR Insider - PrimeraDx Readying ICEPlex, C. Diff Assay for FDA; Developing Follow-on Infectious Disease Panels
May 2, 2013 / PCR Insider - PrimeraDx Back-Burners Infectious Disease Testing to Optimize Multiplex PCR Platform for Oncology, CDx
May 24, 2012 / PCR Insider - PrimeraDx Bolsters CDx Development Efforts with Quest Diagnostics Agreement
March 28, 2013 / PCR Insider - Dx Focus: PrimeraDx, Lilly Ink CDx Deal; Response Genetics Offers New ALK Testing Program
June 28, 2012 / PCR Insider